Carregant...
IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY
INTRODUCTION: Adoptive T cell immunotherapy (ACT) leads to extension of median survival and long-term cures of treatment-resistant models of malignant glioma, medulloblastoma, and pontine gliomas. While very promising, tailored strategies to overcome ACT failure are needed. Therefore, we studied the...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216297/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.535 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|